Studies on the constituents of Broussonetia species. II six new pyrrolidine alkaloids, broussonetine A, B, E, F and broussonetinine A and B, as inhibitors of glycosidases from Broussonetia kazinoki SIEB

Chemical and Pharmaceutical Bulletin

Volumn 45, Issue 4, 1997, Pages 700-705

  Shibano, Makio ^a   Kitagawa, Satoshi ^a   Nakamura, Satoko ^a   Akazawa, Naomi ^a   Kusano, Genjiro ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Broussonetia kazinoki; broussonetine; broussonetinine; glycosidase inhibitor; pyrrolidine alkaloid

Indexed keywords

BETA GALACTOSIDASE; BETA GLUCOSIDASE; BETA MANNOSIDASE; BROUSSONETINE A; BROUSSONETINE B; BROUSSONETINE E; BROUSSONETINE F; GLYCOSIDASE INHIBITOR; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; SPECIES DIFFERENTIATION; STRUCTURE ACTIVITY RELATION;

EID: 0030939363     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.45.700     Document Type: Article

References (9)

1. Shibano M., Kitagawa S., Kusano G., Chem. Pharm. Bull., 45, 505-508 (1997).
2. Shibano M., Kitagawa S., Kusano G., Abstracts of Papers, 37th Symposium of the Chemistry of Natural Products, Tokushima, 1995, 433-438.
3. a) Grusters R. A., Neefjet J. J., Tersmette M., de Goede R. E. Y., Tulp A., Huisman H. G., Miedeman F., Ploegh H. L., Nature (London), 330, 74-77 (1987);
4. b) Elbein A. D., Ann. Rev. Biochem., 56, 497-534 (1987);
5. c) Winchester B., Fleet G. W. J., Glycobiology, 2, 199-210 (1992);
6. d) Look G. C., Fotsch C. H., Wong C. H., Acc. Chem. Res., 26, 182-190 (1993);
7. e) G. S. Jacob, Current Opinion in Structural Biology, 5, 605-611 (1995).
8. Kusano A., Shibano M., Kusano G., Miyase T., Chem. Pharm. Bull., 44, 2078-2085 (1996).
9. Kusano A., Shibano M., Kitagawa S., Kusano G., Nozoe S., Fushiya S., Chem. Pharm. Bull., 42, 1940-1943 (1994).